BG
CLVS

BlackRock Group’s Clovis Oncology, Inc. CLVS Stock Holding History

BlackRock Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$930K Sell
20,918
-5,342
-20% -$188K ﹤0.01% 2162
2016
Q3 		$947K Buy
26,260
+8,335
+46% +$179K ﹤0.01% 2062
2016
Q2 		$246K Sell
17,925
-2,825
-14% -$41.3K ﹤0.01% 2505
2016
Q1 		$398K Buy
20,750
+3,895
+23% +$82.4K ﹤0.01% 2325
2015
Q4 		$589K Buy
16,855
+789
+5% +$50.9K ﹤0.01% 2128
2015
Q3 		$1.48M Buy
16,066
+4,887
+44% +$423K ﹤0.01% 1664
2015
Q2 		$982K Buy
11,179
+5,307
+90% +$454K ﹤0.01% 1970
2015
Q1 		$435K Buy
5,872
+1,063
+22% +$75.1K ﹤0.01% 2247
2014
Q4 		$269K Buy
4,809
+385
+9% +$20.2K ﹤0.01% 2430
2014
Q3 		$201K Sell
4,424
-110
-2% -$4.59K ﹤0.01% 2452
2014
Q2 		$188K Sell
4,534
-4,874
-52% -$251K ﹤0.01% 2473
2014
Q1 		$652K Buy
9,408
+2,216
+31% +$163K ﹤0.01% 2151
2013
Q4 		$433K Sell
7,192
-23,798
-77% -$1.29M ﹤0.01% 2256
2013
Q3 		$1.88M Sell
30,990
-29,589
-49% -$2.1M ﹤0.01% 1504
2013
Q2 		$4.06M Buy
+60,579
New +$2.72M ﹤0.01% 1033

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return